QIAGEN Reports Results for Fourth Quarter and Full-year 2017, Announces STAT-Dx Acquisition and New $200 Million Share Repurchase

Go back to QIAGEN Reports Results for Fourth Quarter and Full-year 2017, Announces STAT-Dx Acquisition and New $200 Million Share Repurchase

Qiagen NV (QGEN) PT Raised to $37.50 at Evercore ISI

February 1, 2018 1:00 PM EST

Evercore ISI raised its price target on Qiagen NV (NASDAQ: QGEN) to $37.50 (from $35.00) while maintaining an Outperform rating follownig results.

Analyst Ross Muken notes Management is comfortable with meeting mid-term targets without the potential contribution from QIAStat. In addition, QIAStat instrument builds on the... More